TUCSON, Ariz., Sept. 12, 2016 -- Medicine is being “fundamentally transformed” into an unaffordable, complex, adversarial, depersonalized labyrinth, writes dermatologist Melinda Woofter, M.D., of Granville, Ohio, in the fall issue of the Journal of American Physicians and Surgeons. Dr. Woofter is currently president of the Association of American Physicians and Surgeons (AAPS).
The direct reason for the unsustainable system, she writes, is government distortion of the marketplace, destroying cost transparency: “Government control of resources always leads to less for everyone. Without natural price signals for market adjustments, costs soar as resources are wrongly allocated, wasted, and squandered.”
In an effort to fix the problem it caused, government resorts to further price controls and still more coercion and restrictions, she explains. Solutions are difficult to find because “government powerholders and third-party cronies who benefit from this will not give up their stranglehold on medicine.”
Dr. Woofter recommends a short new primer analyzing the causes of the high costs and deteriorating quality of American medicine: Common Sense Medicine: Restoring the Patient/Physician Relationship by Jeff Danby. The key is not to pass more laws and regulations, but to restore natural price discovery between patients and doctors, Danby writes.
The Journal of American Physicians and Surgeons is published by the Association of American Physicians and Surgeons (AAPS), a national organization representing physicians in all specialties since 1943.
Contact: Jane M. Orient, M.D., (520) 323-3110, janeorientmd@gmail., or Melinda Woofter, M.D., [email protected]


Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 



